Search research articles
Contact Us
Filters
Showing results (171-180 of 214) with videos related to
Page
of 22
Sort By:
Journal of the National Cancer Institute
|
November 1, 2014
ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer
Lindsay A Renfro, Axel Grothey, Yuan Xue, et al.
Future Oncology (London, England)
|
November 18, 2022
Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial
Brian H Ramnaraign, Ji-Hyun Lee, Azka Ali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2013
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial
Josep Tabernero, Eric Van Cutsem, Radek Lakomý, et al.
JAMA Oncology
|
December 23, 2016
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials
Frank A Sinicrope, Qian Shi, Carmen J Allegra, et al.
JAMA Oncology
|
June 9, 2016
Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial
Nan Song, Katherine L Pogue-Geile, Patrick G Gavin, et al.
Journal of Hematology & Oncology
|
March 9, 2022
BCL-X<sub>L</sub> PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRAS<sup>G12C</sup>-mutated cancers
Sajid Khan, Janet Wiegand, Peiyi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
A Phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumors
J L Grem, J M Sorensen, E Cullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2002
Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer
Carmen J Allegra, Allyson L Parr, Lester E Wold, et al.
Clinical Therapeutics
|
August 27, 1999
Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group
G Sussman, J Shurman, M R Creed, et al.
Plos One
|
August 18, 2018
Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations
Rekha Pal, Ning Wei, Nan Song, et al.
Page
of 22
Search research articles
Search
Showing results (171-180 of 214) with videos related to
Sort By:
Page
of 22
Journal of the National Cancer Institute
|
November 1, 2014
ACCENT-based web calculators to predict recurrence and overall survival in stage III colon cancer
Lindsay A Renfro, Axel Grothey, Yuan Xue, et al.
Future Oncology (London, England)
|
November 18, 2022
Atezolizumab plus tivozanib for immunologically cold tumor types: the IMMCO-1 trial
Brian H Ramnaraign, Ji-Hyun Lee, Azka Ali, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2013
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial
Josep Tabernero, Eric Van Cutsem, Radek Lakomý, et al.
JAMA Oncology
|
December 23, 2016
Association of DNA Mismatch Repair and Mutations in BRAF and KRAS With Survival After Recurrence in Stage III Colon Cancers : A Secondary Analysis of 2 Randomized Clinical Trials
Frank A Sinicrope, Qian Shi, Carmen J Allegra, et al.
JAMA Oncology
|
June 9, 2016
Clinical Outcome From Oxaliplatin Treatment in Stage II/III Colon Cancer According to Intrinsic Subtypes: Secondary Analysis of NSABP C-07/NRG Oncology Randomized Clinical Trial
Nan Song, Katherine L Pogue-Geile, Patrick G Gavin, et al.
Journal of Hematology & Oncology
|
March 9, 2022
BCL-X<sub>L</sub> PROTAC degrader DT2216 synergizes with sotorasib in preclinical models of KRAS<sup>G12C</sup>-mutated cancers
Sajid Khan, Janet Wiegand, Peiyi Zhang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 28, 1999
A Phase I study of raltitrexed, an antifolate thymidylate synthase inhibitor, in adult patients with advanced solid tumors
J L Grem, J M Sorensen, E Cullen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 29, 2002
Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer
Carmen J Allegra, Allyson L Parr, Lester E Wold, et al.
Clinical Therapeutics
|
August 27, 1999
Intravenous ondansetron for the control of opioid-induced nausea and vomiting. International S3AA3013 Study Group
G Sussman, J Shurman, M R Creed, et al.
Plos One
|
August 18, 2018
Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations
Rekha Pal, Ning Wei, Nan Song, et al.
Page
of 22